In the Western blots about 50% normal and 60% CML samples showed a drop in rhoA levels at early time points of fMLP stimulation, resulting in a 20% drop in average rhoA levels. This evidence concerns the gene RHOA and chronic myelogenous leukemia, BCR-ABL1 positive.